Literature DB >> 21998106

Nasal cavity eosinophilic angiocentric fibrosis: CT and MR imaging findings.

B T Yang1, Y Z Wang, X Y Wang, Z C Wang.   

Abstract

BACKGROUND AND
PURPOSE: EAF consists of exceedingly rare lesions and presently lacks specific imaging reports. The purpose of this study was to determine the CT and MR imaging features of nasal cavity EAF.
MATERIALS AND METHODS: We retrospectively reviewed 6 patients with histology-proven EAF in the nasal cavity. All 6 patients underwent CT and 3 patients also underwent MR imaging. The following imaging features were reviewed: 1) location, 2) shape, 3) margin, 4) CT attenuation, and 5) MR imaging signal intensity. In addition, the accompanying changes and the TIC of the DCE MR imaging were analyzed.
RESULTS: All occurrences of EAF were located at the anterior nasal cavity, arising from the nasal septum in 4 patients, with irregular shape, and the lateral nasal wall in 2, with oval configuration. The mean size was 29.8 mm (range 12-52 mm). On nonenhanced CT, EAF lesions appeared isoattenuated relative to gray matter. On the T1-weighted image, the lesions were isointense in 3 (100%) patients. On the T2-weighted image, the lesions were isointense in 1 (33.3%) patient and hypointense in 2 (66.7%) patients. Occurrences of EAF revealed moderate inhomogeneous contrast enhancement. Three patients underwent DCE MR imaging and the TICs exhibited a rapidly enhancing and slow washout pattern. One patient had bilateral lacrimal gland enlargement, which displayed low signal intensity on the T2-weighted image.
CONCLUSIONS: A familiarity with imaging findings, including lesion location, isoattenuation and bony changes, and hypointensity on T2-weighted images may help to accurately diagnose this rare entity.

Entities:  

Mesh:

Year:  2011        PMID: 21998106      PMCID: PMC7964381          DOI: 10.3174/ajnr.A2786

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  24 in total

1.  MR imaging of nasal T-cell/natural killer cell lymphoma.

Authors:  A D King; K I Lei; A T Ahuja; W W Lam; C Metreweli
Journal:  AJR Am J Roentgenol       Date:  2000-01       Impact factor: 3.959

2.  Potentially distinctive features of sinonasal inverted papilloma on MR imaging.

Authors:  H Ojiri; M Ujita; S Tada; K Fukuda
Journal:  AJR Am J Roentgenol       Date:  2000-08       Impact factor: 3.959

3.  Orbital eosinophilic angiocentric fibrosis case report and review of the literature.

Authors:  Igal Leibovitch; Craig L James; Peter J Wormald; Dinesh Selva
Journal:  Ophthalmology       Date:  2005-12-01       Impact factor: 12.079

Review 4.  Eosinophilic angiocentric fibrosis affecting the nasal cavity. A mucosal variant of the skin lesion granuloma faciale.

Authors:  B V Burns; P F Roberts; J De Carpentier; A P Zarod
Journal:  J Laryngol Otol       Date:  2001-03       Impact factor: 1.469

Review 5.  Nasal fibrosis: long-term follow up of four cases of eosinophilic angiocentric fibrosis.

Authors:  Santdeep Paun; Valerie J Lund; Andrew Gallimore
Journal:  J Laryngol Otol       Date:  2005-02       Impact factor: 1.469

6.  Midline necrotizing nasal lesions: analysis of 18 cases emphasizing radiological and serological findings with algorithms for diagnosis and management.

Authors:  Richard W Westreich; William Lawson
Journal:  Am J Rhinol       Date:  2004 Jul-Aug

Review 7.  Eosinophilic angiocentric fibrosis of the sinonasal tract in a male patient with chronic bowel inflammation.

Authors:  Youval Slovik; Marc Putterman; Michael Nash; Netta Sion-Vardy
Journal:  Am J Rhinol       Date:  2006 Jan-Feb

8.  Eosinophilic angiocentric fibrosis of the sinonasal tract.

Authors:  Ognjen Kosarac; Mario A Luna; Jae Y Ro; Alberto G Ayala
Journal:  Ann Diagn Pathol       Date:  2007-10-03       Impact factor: 2.090

9.  Eosinophilic angiocentric fibrosis of the orbit.

Authors:  Hayyam Kiratli; Sevgen Onder; Sibel Yildiz; Havva Ozşeker
Journal:  Clin Exp Ophthalmol       Date:  2008-04       Impact factor: 4.207

10.  Salivary gland tumors: diagnostic value of gadolinium-enhanced dynamic MR imaging with histopathologic correlation.

Authors:  Hidetake Yabuuchi; Tatsuro Fukuya; Tsuyoshi Tajima; Yoichi Hachitanda; Kichinobu Tomita; Mitsuru Koga
Journal:  Radiology       Date:  2003-02       Impact factor: 11.105

View more
  8 in total

1.  Nasal Framework Reconstruction in Patient with Eosinophilic Angiocentric Fibrosis.

Authors:  Amir Arvin Sazgar; Sahand Kia; Armin Akbari
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-07-18

2.  Nasal Eosinophilic Angiocentric Fibrosis with Orbital Extension.

Authors:  Mohammad Faramarzi; Mohammad Hossein Dadgarnia; Mansour Moghimi; Hadi Sharouny; Nasim Behniafard
Journal:  Head Neck Pathol       Date:  2015-01-20

3.  Eosinophilic Angiocentric Fibrosis of Sinonasal Region: A Rare & Under Reported Entity.

Authors:  Aminder Singh; Pavneet Kaur Selhi; Manish Munjal; Neena Sood
Journal:  J Clin Diagn Res       Date:  2015-11-01

4.  Neoadjuvant use of methotrexate in eosinophilic angiocentric fibrosis of upper lip and hard palate: A case report.

Authors:  Francesca Nastro; Angelo Ruggiero; Gustavo Spanò; Sara Cacciapuoti; Mariateresa Cantelli; Gabriella Fabbrocini; Claudio Marasca
Journal:  Dermatol Ther       Date:  2021-08-13       Impact factor: 3.858

5.  Eosinophilic Angiocentric Fibrosis as a Stenosing Lesion in the Subglottis.

Authors:  Ivan Keogh; Rohana O'Connell; Sean Hynes; John Lang
Journal:  Case Rep Otolaryngol       Date:  2017-01-30

Review 6.  Eosinophilic angiocentric fibrosis of the sinonasal tract: a case report and review of the literature.

Authors:  Etrat Javadirad; Narges Eskandari Roozbahani; Sepehr Sadafi
Journal:  J Int Med Res       Date:  2022-09       Impact factor: 1.573

7.  Eosinophilic angiocentric fibrosis of the nasal septum.

Authors:  Yunchuan Li; Honggang Liu; Demin Han; Hongrui Zang; Tong Wang; Bin Hu
Journal:  Case Rep Otolaryngol       Date:  2013-03-24

8.  Eosinophilic angiocentric fibrosis of the sinonasal tract.

Authors:  Chunzi Jenny Jin; Bayardo Perez-Ordonez; Ian Witterick
Journal:  BJR Case Rep       Date:  2016-05-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.